Curbing inappropriate C. difficile treatment in patients receiving concomitant laxatives
Open Access
- 17 February 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e50
Abstract
In the setting of universal Clostridioides difficile screening, we implemented an alert that triggered when C. difficile treatment was ordered in patients who recently received laxatives. This resulted in C. difficile treatment avoidance in 37% of patients and was associated with drug cost savings of $143,905 over a 10-month period.Keywords
This publication has 5 references indexed in Scilit:
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clinical Infectious Diseases, 2018
- Overdiagnosis ofClostridium difficileInfection in the Molecular Test EraJAMA Internal Medicine, 2015
- Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing EraInfection Control & Hospital Epidemiology, 2014
- Nosocomial Diarrhea: Evaluation and Treatment of Causes Other Than Clostridium difficileClinical Infectious Diseases, 2012
- Development and Validation of a Clostridium difficile Infection Risk Prediction ModelInfection Control & Hospital Epidemiology, 2011